Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

Europe - BIT:1SHL - DE000SHL1006 - Common Stock

45.67 EUR
-1.93 (-4.05%)
Last: 9/29/2025, 7:00:00 PM
Fundamental Rating

5

Overall 1SHL gets a fundamental rating of 5 out of 10. We evaluated 1SHL against 60 industry peers in the Health Care Equipment & Supplies industry. 1SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1SHL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1SHL had positive earnings in the past year.
In the past year 1SHL had a positive cash flow from operations.
In the past 5 years 1SHL has always been profitable.
In the past 5 years 1SHL always reported a positive cash flow from operatings.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

1SHL has a Return On Assets of 4.87%. This is in the better half of the industry: 1SHL outperforms 65.57% of its industry peers.
1SHL has a better Return On Equity (12.29%) than 75.41% of its industry peers.
1SHL has a Return On Invested Capital of 7.89%. This is in the better half of the industry: 1SHL outperforms 70.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1SHL is below the industry average of 9.00%.
The 3 year average ROIC (5.87%) for 1SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.87%
ROE 12.29%
ROIC 7.89%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

With a decent Profit Margin value of 9.29%, 1SHL is doing good in the industry, outperforming 67.21% of the companies in the same industry.
1SHL's Profit Margin has declined in the last couple of years.
The Operating Margin of 1SHL (13.76%) is better than 63.93% of its industry peers.
1SHL's Operating Margin has declined in the last couple of years.
1SHL has a worse Gross Margin (38.76%) than 73.77% of its industry peers.
In the last couple of years the Gross Margin of 1SHL has remained more or less at the same level.
Industry RankSector Rank
OM 13.76%
PM (TTM) 9.29%
GM 38.76%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SHL is creating some value.
1SHL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1SHL has more shares outstanding
Compared to 1 year ago, 1SHL has an improved debt to assets ratio.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

1SHL has an Altman-Z score of 2.04. This is not the best score and indicates that 1SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
1SHL has a Altman-Z score of 2.04. This is comparable to the rest of the industry: 1SHL outperforms 45.90% of its industry peers.
1SHL has a debt to FCF ratio of 5.10. This is a neutral value as 1SHL would need 5.10 years to pay back of all of its debts.
1SHL's Debt to FCF ratio of 5.10 is in line compared to the rest of the industry. 1SHL outperforms 59.02% of its industry peers.
1SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating 1SHL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, 1SHL is doing worse than 68.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.1
Altman-Z 2.04
ROIC/WACC1.28
WACC6.17%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1SHL has a Current Ratio of 1.12. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
1SHL has a worse Current ratio (1.12) than 67.21% of its industry peers.
A Quick Ratio of 0.77 indicates that 1SHL may have some problems paying its short term obligations.
1SHL has a worse Quick ratio (0.77) than 67.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.77
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

1SHL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.21%, which is quite good.
1SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
The Revenue has been growing slightly by 5.85% in the past year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%

3.2 Future

The Earnings Per Share is expected to grow by 9.71% on average over the next years. This is quite good.
1SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.62% yearly.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.19, the valuation of 1SHL can be described as rather expensive.
1SHL's Price/Earnings ratio is rather cheap when compared to the industry. 1SHL is cheaper than 83.61% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.03. 1SHL is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 17.47 indicates a rather expensive valuation of 1SHL.
Based on the Price/Forward Earnings ratio, 1SHL is valued a bit cheaper than the industry average as 72.13% of the companies are valued more expensively.
1SHL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.19
Fwd PE 17.47
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SHL indicates a somewhat cheap valuation: 1SHL is cheaper than 65.57% of the companies listed in the same industry.
88.52% of the companies in the same industry are more expensive than 1SHL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.75
EV/EBITDA 14.19
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1SHL may justify a higher PE ratio.
PEG (NY)1.98
PEG (5Y)2.64
EPS Next 2Y8.26%
EPS Next 3Y9.53%

6

5. Dividend

5.1 Amount

1SHL has a Yearly Dividend Yield of 1.96%.
1SHL's Dividend Yield is rather good when compared to the industry average which is at 2.13. 1SHL pays more dividend than 80.33% of the companies in the same industry.
1SHL's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.96%

5.2 History

The dividend of 1SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1SHL pays out 49.08% of its income as dividend. This is a bit on the high side, but may be sustainable.
1SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (9/29/2025, 7:00:00 PM)

45.67

-1.93 (-4.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/dmh
Earnings (Next)11-05 2025-11-05/amc
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.52B
Revenue(TTM)23.38B
Net Income(TTM)2.17B
Analysts83.7
Price Target61.96 (35.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.96%
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0.36%
PT rev (3m)-0.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 19.19
Fwd PE 17.47
P/S 2.2
P/FCF 16.75
P/OCF 13.39
P/B 2.91
P/tB N/A
EV/EBITDA 14.19
EPS(TTM)2.38
EY5.21%
EPS(NY)2.61
Fwd EY5.72%
FCF(TTM)2.73
FCFY5.97%
OCF(TTM)3.41
OCFY7.47%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)1.98
PEG (5Y)2.64
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 12.29%
ROCE 10.07%
ROIC 7.89%
ROICexc 8.64%
ROICexgc 46.76%
OM 13.76%
PM (TTM) 9.29%
GM 38.76%
FCFM 13.16%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexgc growth 3Y-8.79%
ROICexgc growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.1
Debt/EBITDA 2.58
Cap/Depr 59.37%
Cap/Sales 3.29%
Interest Coverage 7.09
Cash Conversion 85.2%
Profit Quality 141.62%
Current Ratio 1.12
Quick Ratio 0.77
Altman-Z 2.04
F-Score8
WACC6.17%
ROIC/WACC1.28
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%

SIEMENS HEALTHINEERS AG / 1SHL.MI FAQ

What is the ChartMill fundamental rating of SIEMENS HEALTHINEERS AG (1SHL.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1SHL.MI.


What is the valuation status for 1SHL stock?

ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (1SHL.MI). This can be considered as Fairly Valued.


How profitable is SIEMENS HEALTHINEERS AG (1SHL.MI) stock?

SIEMENS HEALTHINEERS AG (1SHL.MI) has a profitability rating of 6 / 10.


What is the financial health of SIEMENS HEALTHINEERS AG (1SHL.MI) stock?

The financial health rating of SIEMENS HEALTHINEERS AG (1SHL.MI) is 3 / 10.


What is the earnings growth outlook for SIEMENS HEALTHINEERS AG?

The Earnings per Share (EPS) of SIEMENS HEALTHINEERS AG (1SHL.MI) is expected to grow by 9.68% in the next year.